Form 8-K - Current report:
SEC Accession No. 0001564590-19-040458
Filing Date
2019-11-05
Accepted
2019-11-05 16:54:44
Documents
5
Period of Report
2019-11-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20191105.htm 8-K 40202
2 EX-1.1 xene-ex11_6.htm EX-1.1 277983
3 EX-5.1 xene-ex51_118.htm EX-5.1 9912
4 GRAPHIC g0vgs1agepmg000002.jpg GRAPHIC 28227
5 GRAPHIC g0vgs1agepmg000001.jpg GRAPHIC 14552
  Complete submission text file 0001564590-19-040458.txt   388421
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 191194052
SIC: 2834 Pharmaceutical Preparations